Day: September 6, 2023

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR HONG KONG, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR OTHER MEASURES. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Aberdeen, 6 September 2023 Reference is made to the stock exchange notice from Awilco Drilling Plc (“Awilco Drilling” or the “Company”) on 22 August 2023 regarding the subsequent offering (the “Subsequent Offering”) of up to 469,400 new sponsored Norwegian depository receipts (the “Offer Shares”) at a subscription price of NOK 9 per Offer Share (the “Offer Price”). The subscription period for the Subsequent...

Brera Brand to Gain International Spotlight in upcoming matches against Sweden, the Netherlands and EswatiniBrera Tchumene in actionBrera Tchumene in actionDUBLIN and MILAN, MAPUTO and STRUMICA, Sept. 06, 2023 (GLOBE NEWSWIRE) — Brera Holdings PLC (“Brera Holdings” or the “Company”, Nasdaq: BREA) announced that nine professional Brera players have been selected to represent their national youth teams. Of these, two hail from Brera Strumica in North Macedonia’s First Division League, while the other seven belong to Brera Tchumene—a top team in Mozambique’s Second League. Marko Alchevski, Brera Strumica’s goalkeeper and captain of the North Macedonia Under-21 national team—who boasts four clean sheets in the first six League matchdays—will represent the team with winger Vane Krstevski in away...

RENO, Nev., Sept. 06, 2023 (GLOBE NEWSWIRE) — Ormat Technologies Inc. (NYSE: ORA), a leading renewable energy company, today announced that it will ring the opening bell at the New York Stock Exchange on Wednesday, September 6th as the Company celebrates entering its 20th year of listing on the exchange. CEO, Doron Blachar, along with colleagues and management members, will be at the Stock Exchange to commemorate this important milestone in the Company’s history. “We are honored to celebrate Ormat’s history as a publicly traded company by ringing the NYSE opening bell,” said Doron Blachar, CEO of Ormat Technologies. “As we reflect on 20 years of trading on the NYSE, I am proud of what we have accomplished, and am particularly proud of the Company’s continued growth in developing and providing geothermal, storage and other renewable...

Latest-generation 1024 Wh battery offers a nearly 15% increase in energy density for stationary storage, C&I applications, and economy passenger and commercial EVsGreat Power’s 320 Ultra Lithium-Ion Battery CellLatest-generation battery offers a nearly 15% increase in energy density for stationary storage, C&I applications, and economy passenger and commercial EVsGUANGZHOU, China, Sept. 06, 2023 (GLOBE NEWSWIRE) — Great Power, a leading global battery manufacturer since 2001, today announced the release of its latest high-capacity lithium-ion battery cell, the 320 Ultra, offering over 1 kWh of energy (320 ampere-hours of capacity). This next-generation battery offers the same reliable and safe lithium iron phosphate (LFP) chemistry and technology but with a significant boost in capacity and cycle life....

HAMILTON, BERMUDA , Sept. 06, 2023 (GLOBE NEWSWIRE) — Altamira Therapeutics Ltd. (“Altamira” or the “Company”) (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced that it will host its First Half of 2023 Financial Results and Business Update Call on Tuesday, September 12, 2023. Founder, Chairman, and CEO Thomas Meyer and COO Covadonga Pañeda will deliver prepared remarks followed by a Q&A session where they will address questions from investors and analysts. Event: Altamira Therapeutics First Half 2023 Financial Results and Business Update CallDate: Tuesday, September 12thTime: 8am ET (5am PT) Access: Toll Free: 888-506-0062International: 973-528-0011Participant Access Code: 500382Webcast URL: https://www.webcaster4.com/Webcast/Page/2797/48993 Investors...

PALO ALTO, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) — Hesai Group (“Hesai” or the “Company”) (NASDAQ: “HSAI”), the global leader in three-dimensional light detection and ranging (“lidar”) solutions, in response to recent inaccurate and misleading information in the market, issued this statement setting the record straight about the Company’s intellectual property assets and record of innovation, data security, and ownership, funding, and management. Hesai BackgroundHesai is a publicly traded and privately owned company that began as a Silicon Valley lidar start-up in San Jose, California (“Hesai” means “Jose” from San Jose in Chinese). It was founded in 2014 by two Stanford University engineering graduates and a University of Illinois Ph.D. Since then, Hesai has grown to become the global leader in designing, developing, and producing...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 06, 2023 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) announced that Larry Jasinski, Chief Executive Officer, will present and host one-on-one meetings with investors virtually at the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023. The presentation will be available via webcast on Monday, September 11, 2023 starting at 7:00 AM EDT and can be accessed through the following link: https://journey.ct.events/view/ea9773fc-c1e1-4ab5-b288-53ea07108cf1. ReWalk will also post this link on the Investors section of our website at rewalk.com where it will be available on-demand for 90 days. About ReWalk Robotics Ltd.ReWalk Robotics Ltd. is a medical device company that designs, develops, and commercializes innovative...

MONTREAL, Sept. 06, 2023 (GLOBE NEWSWIRE) — Stingray (TSX: RAY.A; RAY.B), a leading global music, media, and technology company, today announced a new distribution agreement with TCL®, one of the world’s best-selling and leading consumer electronics companies. Their TCLtv+ app is a new online streaming service that allows its customers in North America access to a wide variety of complimentary entertainment programming. This groundbreaking deal brings Stingray’s innovative channels, including the debut of Ultimate Trivia, to TCLtv+ users, enhancing their entertainment experience with a diverse range of music and specialty content. Now available on Google and coming soon to Roku and FireTV smart operating systems, the TCLtv+ app includes more than 200 FAST (Free Ad-Supported Streaming Television) channels and 1500+ on-demand...

Journey to receive an upfront payment of $19 million SCOTTSDALE, Ariz., Sept. 06, 2023 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”) approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced it has entered into an exclusive license agreement (the “Agreement”) with Maruho Co., Ltd. (“Maruho”), a Japanese company specializing in dermatology and also Journey’s exclusive licensing partner that developed and is commercializing Qbrexza (Rapifort®) in Japan. Pursuant to the terms of the Agreement, Journey Medical granted Maruho an exclusive license to develop and commercialize Qbrexza® (Rapifort®...

mRNA cell engineering strategically targets genes to create novel and potentially superior product profiles for cell transplant therapy applications Novel engineered iPS cell line to be evaluated by Lineage for potential development of cell transplant therapies for central nervous system diseases under collaboration initiated in early 2023 Lineage to make milestone payments to Eterna in connection with Eterna’s successful development and delivery to Lineage of certain materials CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna”), a life science company committed to realizing the potential of mRNA cell engineering to provide patients with transformational new medicines, today announced the initiation of certain development activities to generate a novel hypoimmune induced pluripotent...